Immage Biotherapeutics

OverviewSuggest Edit

Immage Biotherapeutics Corp. is a biotechnology company, develops novel immunotherapy biologics to treat various cancers in the United States. It focuses on the development, marketing, and licensing of its patented immunotherapy candidate IMT-001, a hybrid/fusion protein vaccine that targets various tumors that express melanoma-associated antigen-A gene, including breast, liver, pancreas, prostate, melanoma, and lung diseases.
TypePublic
Founded2015
HQBethesda, US
Websiteimmagebio.com

Recent NewsAll News

Latest Updates

Employees (est.) (Feb 2019)3(+50%)
Share Price (Sept 2020)$0
Cybersecurity ratingAMore

Immage Biotherapeutics Office Locations

Immage Biotherapeutics has an office in Bethesda
Bethesda, US (HQ)
10411 Motor City Dr #750
Show all (1)

Immage Biotherapeutics Financials and Metrics

Immage Biotherapeutics Revenue

USD

Net income (Q2, 2017)

(44.1k)

Market capitalization (17-Sept-2020)

15.2k

Closing stock price (17-Sept-2020)

0.0

Cash (28-Feb-2017)

53.7k

EV

(38.4k)
Immage Biotherapeutics's current market capitalization is $15.2 k.
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016

General and administrative expense

3.1k11.0k98.9k

R&D expense

62.2k

Operating expense total

3.1k11.0k161.1k

EBIT

(18.6k)
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017

General and administrative expense

1.1k2.2k839.0685.02.0k1.5k4.3k19.8k27.3k26.0k28.0k24.4k

R&D expense

34.7k9.7k1.6m5.7k

Operating expense total

1.1k2.2k839.0685.02.0k1.5k4.3k19.8k62.0k35.7k1.7m30.1k

EBIT

(4.1k)(9.7k)(4.5k)
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

7.2k2.3k32.7k196.7k

Accounts Receivable

269.2m

Prepaid Expenses

904.0

Current Assets

33.6k205.0k
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017

Cash

5.7k833.04.2k802.023.023.075.0k383.6k327.8k265.5k127.1k53.7k

Prepaid Expenses

5.8k3.3k

Current Assets

75.0k383.6k327.8k265.5k133.0k57.0k

PP&E

38.3k36.3k34.2k30.1k28.1k
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

(12.0k)(18.6k)(53.9k)(216.5k)

Depreciation and Amortization

764.08.5k

Accounts Payable

150.01.7k(444.0)

Cash From Operating Activities

(11.9k)(52.4k)(215.8k)
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017

Net Income

(9.0k)(10.6k)(13.3k)(17.4k)(9.7k)(14.2k)(36.7k)(34.0k)(103.6k)(154.5k)(1.7m)(1.7m)

Depreciation and Amortization

2.3k4.6k6.9k2.1k4.3k

Accounts Payable

860.01.8k1.8k2.0k7.4k11.9k7.1k4.4k13.3k(413.0)45.1k12.7k

Cash From Operating Activities

(8.2k)(8.8k)(11.5k)(15.4k)(2.3k)(2.3k)(29.5k)(25.6k)(84.8k)(147.0k)(71.1k)(143.0k)
USDQ3, 2013

Financial Leverage

-1 x
Show all financial metrics

Immage Biotherapeutics Cybersecurity Score

Cybersecurity ratingPremium dataset

A

93/100

SecurityScorecard logo

Immage Biotherapeutics Online and Social Media Presence

Embed Graph

Immage Biotherapeutics Blogs

Immage Biotherapeutics Frequently Asked Questions

  • When was Immage Biotherapeutics founded?

    Immage Biotherapeutics was founded in 2015.

  • How many employees does Immage Biotherapeutics have?

    Immage Biotherapeutics has 3 employees.

  • Who are Immage Biotherapeutics competitors?

    Competitors of Immage Biotherapeutics include CytoTools, Codiak Biosciences and Vitrolife.

  • Where is Immage Biotherapeutics headquarters?

    Immage Biotherapeutics headquarters is located at 10411 Motor City Dr #750, Bethesda.

  • Where are Immage Biotherapeutics offices?

    Immage Biotherapeutics has an office in Bethesda.

  • How many offices does Immage Biotherapeutics have?

    Immage Biotherapeutics has 1 office.